DelMar Pharmaceuticals Inc Stock OTC Bulletin Board
Equities
DMPI
US2470781087
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-14 | Kintara Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
04-03 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.82M 9.34M |
---|---|---|---|---|---|
Net income 2022 | -22M -30.12M | Net income 2023 | -14M -19.17M | EV / Sales 2022 | - |
Net cash position 2022 | 11.78M 16.13M | Net cash position 2023 | 2.61M 3.57M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.54
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.87% |
Latest transcript on DelMar Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 18-04-10 |
Greg Johnson
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 18-04-10 |
Tamara Favorito
BRD | Director/Board Member | 65 | 21-04-28 |
Laura Douglass
BRD | Director/Board Member | 59 | 20-06-25 |
1st Jan change | Capi. | |
---|---|---|
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- KTRA Stock
- DMPI Stock